Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2026-01-26 @ 11:20 AM
Study NCT ID:
NCT04184518
Status:
WITHDRAWN
Last Update Posted:
2020-06-02
First Post:
2019-11-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Durvalumab (MEDI4736) Plus Cediranib in Patients With Metastatic Uveal Melanoma
Sponsor:
Grupo Español Multidisciplinar de Melanoma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-12
Completion Date Type:
ESTIMATED
First Submit Date:
2019-11-29
First Submit QC Date:
None
Study First Post Date:
2019-12-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-29
Last Update Post Date:
2020-06-02
Last Update Post Date Type:
ACTUAL